Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn’s Disease: A Systematic Review-Reference-Cited by-同舟云学术

Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn’s Disease: A Systematic Review

Published:2018-09 Issue:9 Volume:16 Page:1407-1419.e22
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Ma Christopher^ORCID,Hussein Isra M.,Al-Abbar Yousef J.,Panaccione Remo,Fedorak Richard N.,Parker Claire E.,Nguyen Tran M.,Khanna Reena,Siegel Corey A.,Peyrin-Biroulet Laurent,Pai Rish K.,Vande Casteele Niels^ORCID,D’Haens Geert R.,Sandborn William J.,Feagan Brian G.,Jairath Vipul

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference145 articles.

1. Evolving concepts in phases I and II drug development for Crohn's disease;Jairath;J Crohns Colitis,2017

2. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target;Peyrin-Biroulet;Am J Gastroenterol,2015

3. United States Food and Drug Administration. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims 2009. Available from: https://www.fda.gov/downloads/drugs/guidances/ucm193282.pdf. Accessed December 15, 2017.

4. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease;Williet;Clin Gastroenterol Hepatol,2014

5. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study—Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID);Mary;Gut,1989

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn’s Disease Activity;Clinical Gastroenterology and Hepatology;2023-12

2. Impact of an Educational Mobile App on Inflammatory Bowel Disease Colonoscopy Report Quality;Digestive Diseases and Sciences;2023-10-05

3. Sarcopenia assessed by computed tomography or magnetic resonance imaging is associated with the loss of response to biologic therapies in adult patients with Crohn's disease;Clinical and Translational Science;2023-09-05

4. A Systematic Review on Long-Term Efficacy Outcome Measures in Crohn’s Disease Patients;Journal of Crohn's and Colitis;2023-03-13

5. Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization;Gastroenterology;2022-11